tbuckley/cabot-search huggingface dataset:
Automated tumor size assessment: Consistency of computer measurements with an expert panel.
Authors: Matthew S. Brown, Hyun J. Kim, Pechin Lo, Eran Barnoy, Michael F. McNitt-Gray, Denise R. Aberle, Jonathan Goldin
Journal: Journal of Clinical Oncology (2013)

7566 Background: Manual tumor measurements for use in diagnosis and longitudinal assessment suffer from intra- and inter-observer variability. In practice they are also limited to 1-dimensional diameter measurements because manual contouring of 3D tumor boundaries is impractical. In this work we evaluated a fully automated tumor assessment system in the setting of lung nodules on CT by comparing its tumor size and density measurements against independent measurements made by an expert panel of radiologists. Methods: A new computer-aided detection (CAD) system has been developed that performs fully automated lung nodule detection and measurement. In order to identify the nodule boundary in 3D the system performs automated intensity thresholding, a Euclidean Distance Transformation, and segmentation based on watersheds. The system computes nodule diameter, volume, and mean density in Hounsfield Units (HU). The automated measurements were evaluated against data from the publically available Lung Imaging Database Consortium (LIDC), where each CT scan was reviewed and annotated (with volumetric tumor contours) by an expert panel of four radiologists. Nodule were included from consecutive subjects in the database that were ≥ 4 mm. The CT slice thickness ranged from 0.6 – 3.0 mm. For each nodule measure, the intra-class correlation coefficient (ICC) was computed among the four radiologists and then re-computed with CAD as a fifth observer. Results: 51 lung nodules from 44 subjects were analyzed. The ICCs were computed as shown in the table using a log transformation for volume and diameter. All nodule measures have similar ICCs and overlapping confidence intervals (CI). Conclusions: A new fully automated CAD system has been developed that provides CT lung nodule measurements that are consistent with an expert panel of radiologists. The automated computer system enables practical 3D tumor assessment and reduces measurement variability, which has implications for longitudinal studies. [Table: see text]
ASSESSMENT OF THE SAFETY OF PERFORMING CORONARY ANGIOPLASTY WITHOUT INTERRUPTING ORAL ANTICOAGULANTS
Authors: Ashraf M. Al Azzoni, Ellen Macrae, Syal Renu, Hussain Alzayer, Chandni Patel, Jon-David Schwalm, Sanjit Jolly, Madhu Natarajan
Journal: Journal of the American College of Cardiology (2017)
The Number of Leukoreduced RBC and Platelet Transfusions Does Not Increase the Incidence of aGVHD in Allogeneic Peripheral Blood Stem Cell Transplant Recipients
Authors: Robert A. DeSimone, Ruchika Goel, Ronit Reich-Slotky, Adrienne Phillips, Usama Gergis, Koen van Besien, Melissa M. Cushing, Ljiljana V. Vasovic
Journal: Blood (2016)
ASSESSMENT OF RIGHT SIDED HEMODYNAMIC PARAMETERS AS PREDICTORS OF EARLY OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
Authors: Mihir Barvalia, Rajiv Tayal, Marc Cohen, Martin Miguel Amor, Lilia Tcharnaia, Emmanuel Achu, Alan Weinberg, Najam Wasty, Mark Russo, Bruce Haik
Journal: Journal of the American College of Cardiology (2017)
CONCORDANCE OF CONVENTIONAL 2D-DOPPLER VERSUS SPECKLE TRACKING ECHOCARDIOGRAPHY-BASED CLASSIFICATION OF LEFT VENTRICULAR DIASTOLIC FUNCTION
Authors: Alaa Mabrouk Salem Omar, Allen Weiss, Sukrit Narula, Megan Cummins, Piedad Lerena Saenz, Ahmad Mahmoud, Mohamed Abdel-Rahman, Osama Rifaie, Partho Sengupta
Journal: Journal of the American College of Cardiology (2017)
Ruxolitinib (RUX) in Combination with Azacytidine (AZA) in Patients (pts) with Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)
Authors: Naval G. Daver, Jorge E. Cortes, Naveen Pemmaraju, Elias J. Jabbour, Prithviraj Bose, Lingsha Zhou, Sherry Pierce, Stephanie Van Derbur, Carla Kay Tuttle, Gautam Borthakur, Zeev Estrov, Guillermo Garcia-Manero, Hagop M. Kantarjian, Srdan Verstovsek
Journal: Blood (2016)
CORONARY CALCIFICATION AS A MECHANISM OF PLAQUE/MEDIA SHRINKAGE: A MULTIMODALITY INTRACORONARY IMAGING STUDY
Authors: Yaping Zeng, Rafael Cavalcante, Carlos Collet, Erhan Tenekecioglu, Yohei Sotomi, Yuki Katagiri, Yosuke Miyazaki, Taku Asano, Mohammad Abdelghani, Shao-Ping Nie, Christos V. Bourantas, Nico Bruining, Yoshinobu Onuma, Patrick W. Serruys
Journal: Journal of the American College of Cardiology (2017)
VAGUS NERVE STIMULATION REQUIRES BOTH IPSILATERAL AND CONTRALATERAL EFFERENT VAGAL ACTIVITY TO FULLY EXERT ITS CARDIOPROTECTION AGAINST CARDIAC ISCHEMIA/REPERFUSION INJURY
Authors: Krekwit Shinlapawittayatorn, Watthana Nuntaphum, Pongpan Tanajak, Savitree Thummasorn, Juthamas Khamseekaew, Suwakon Wongjaikam, Siriporn Chattipakorn, Nipon Chattipakorn
Journal: Journal of the American College of Cardiology (2017)
Trustworthiness perception at zero acquaintance: Consensus, accuracy, and prejudice
Authors: Jean-François Bonnefon, Astrid Hopfensitz, Wim De Neys
Journal: Behavioral and Brain Sciences (2017)

Abstract Research on trustworthiness perception from faces has unfolded in a way that is strikingly reminiscent of Jussim's narrative in his 2012 book. Jussim's analysis warns us against overemphasizing evidence about prejudice over evidence about accuracy, when both are scant; and reminds us to hold all accounts to the same standards, whether they call on societal biases or true signals.
PROGNOSTIC VALUE OF RIGHT VENTRICULAR FUNCTION ASSESSED BY CARDIAC COMPUTED TOMOGRAPHY IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
Authors: Yohannes Aberra Bayissa, Firas Zahr, Rami Kafa, Hazim El-Haddad, Andres Vargas Estrada, Chad Ward, Musab Alqasrawi, Gardar Sigurdsson
Journal: Journal of the American College of Cardiology (2017)
RACIAL DIFFERENCES IN LEFT VENTRICULAR RECOVERY IN PATIENTS WITH PERIPARTUM CARDIOMYOPATHY ASSESSED BY GLOBAL LONGITUDINAL STRAIN
Authors: Masataka Sugahara, Dennis McNamara, Joan Briller, Leslie Cooper, Julie Damp, Mark Drazner, James Fett, Eileen Hsich, Navin Rajagopalan, John Gorcsan
Journal: Journal of the American College of Cardiology (2017)
USEFULNESS OF LEFT VENTRICULAR SPECKLE TRACKING ECHOCARDIOGRAPHY IN DIAGNOSING PAROXYSMAL ATRIAL FIBRILLATION IN ISCHEMIC STROKE AND TRANSIENT ISCHEMIC ATTACK PATIENTS
Authors: Kristoffer Skaarup, Hanne K. Christensen, Nis Host, Maasti M. Mahmoud, Christian A. Ovesen, Flemming Javier Olsen, Jan Skov Jensen, Tor Biering-Sorensen
Journal: Journal of the American College of Cardiology (2017)
REFINING THE CLASSIFICATION OF SEVERE, SYMPTOMATIC AORTIC STENOSIS USING FLOW AND GRADIENT MEASUREMENTS TO PREDICT OUTCOMES POST-TRANSCATHETER AORTIC VALVE REPLACEMENT
Authors: Matthew Brinkman, Amisha Patel, Cheng-Han Chen, Tamim Nazif, Omar Khalique, Ming Liao, Torsten Vahl, Isaac George, Pablo Codner, Remi Kouz, Juan Terre, Jennifer Jantz, Martin Leon, Susheel Kodali, Rebecca Hahn
Journal: Journal of the American College of Cardiology (2017)
Investigation of <i>Salmonella</i> Enteritidis Outbreak Associated with Truffle Oil — District of Columbia, 2015
Authors: S. Janet Kuramoto-Crawford, Sasha McGee, Keith Li, Andrew K. Hennenfent, Kossia Dassie, Jhetari T. Carney, Arian Gibson, Ivory Cooper, Morris Blaylock, Reginald Blackwell, Angela Fields, John Davies-Cole
Journal: MMWR Morbidity and Mortality Weekly Report (2017)

On September 8, 2015, the District of Columbia Department of Health (DCDOH) received a call from a person who reported experiencing gastrointestinal illness after eating at a District of Columbia (DC) restaurant with multiple locations throughout the United States (restaurant A). Later the same day, a local emergency department notified DCDOH to report four persons with gastrointestinal illness, all of whom had eaten at restaurant A during August 30-September 5. Two patients had laboratory-confirmed Salmonella group D by stool culture. On the evening of September 9, a local newspaper article highlighted a possible outbreak associated with restaurant A. Investigation of the outbreak by DCDOH identified 159 patrons who were residents of 11 states and DC with gastrointestinal illness after eating at restaurant A during July 1-September 10. A case-control study was conducted, which suggested truffle oil-containing food items as a possible source of Salmonella enterica serotype Enteritidis infection. Although several violations were noted during the restaurant inspections, the environmental, laboratory, and traceback investigations did not confirm the contamination source. Because of concern about the outbreak, the restaurant's license was suspended during September 10-15. The collaboration and cooperation of the public, media, health care providers, and local, state, and federal public health officials facilitated recognition of this outbreak involving a pathogen commonly implicated in foodborne illness.
Impact of Incomplete Blood Count Recovery Prior to Allogeneic Hematopoietic Stem Cell Transplantation on Engraftment and Early Infection in Patients with Acute Myeloid Leukemia
Authors: Takeru Asano, Shuntaro Ikegawa, Tomoko Inomata, Naoto Ikeda, Hiroyuki Sugiura, Taiga Kuroi, Shohei Yoshida, Hisakazu Nishimori, Ken-ichi Matsuoka, Nobuharu Fujii, Eisei Kondo, Yoshinobu Maeda, Mitsune Tanimoto
Journal: Blood (2016)
Diabetologist and former journal editor faces charges of data fabrication
Authors: Clare Dyer
Journal: BMJ (2017)

A consultant diabetologist who edited the British Journal of Diabetes from 2014 to 2016 is facing allegations by the General Medical Council that he fabricated research data.

Paul Grant was also appointed editor in chief of Clinical Medicine , the journal of the Royal College of Physicians, before the allegations emerged but never took up the post.

At a four week hearing of the Medical Practitioners Tribunal Service that opened on 13 March, the GMC accuses Grant of a catalogue of research misconduct, including forging the signatures of coauthors, listing doctors who had not significantly contributed to papers as coauthors, and fabricating data.

The …
ASSESSMENT OF LEFT VENTRICULAR ROTATIONAL MECHANICS POST-LVAD IMPLANTATION USING 3D ECHOCARDIOGRAPHY
Authors: Diego Medvedofsky, Gabriel Sayer, Lynn Weinert, Eric Kruse, Megan Yamat, Victor Mor-Avi, Amit Patel, Karima Addetia, Sirtaz Adatya, Nitasha Sarswat, Gene Kim, Takeyoshi Ota, Valluvan Jeevanandam, Nir Uriel, Roberto Lang
Journal: Journal of the American College of Cardiology (2017)
Patients should have free and immediate access to all information related to clinical trials
Authors: Peter C Gøtzsche
Journal: BMJ (2017)

Mendel and colleagues highlight the problem of unethical trials getting approved by research ethics committees while the participating patients are kept in the dark.1

I agree with their proposals but not with their statement that “the difficulties in accessing basic ethics documents means that [a systematic review] is unlikely to be feasible.” We are doing exactly this. At the Nordic Cochrane Centre, we have extracted data from a cohort of …
RISK ASSESSMENT OF RECURRENT ATRIAL FIBRILLATION AFTER ANTIARRHYTHMIC MEDICATION OR CATHETER ABLATION: THE IMPACT OF AGE AND SUPRAVENTRICULAR ECTOPIC COMPLEXES
Authors: Christina Alhede, Arne Johannessen, Ulrik Dixen, Jan Jensen, Pekka Raatikainen, Gerhard Hindricks, Hakan Walfridsson, Ole Kongstad, Steen Pehrson, Anders Englund, Juha Hartikainen, Peter Steen Hansen, Jens Nielsen, Christian Jons
Journal: Journal of the American College of Cardiology (2017)
Incidence of inconsistent driver mutations between multiple lung ground-glass nodules in patients with non-small cell lung cancer.
Authors: Shengxiang Ren, Chunyan Wu, Xuefei Li, Chao Zhao, Likun Hou, Caicun Zhou
Journal: Journal of Clinical Oncology (2014)

11068 Background: Intertumor heterogeneity had been observed in various kinds of malignant tumors including non-small cell lung cancer. Comparing with extra-pulmonary metastasis, patients with multiple pulmonary nodules have a significantly higher rate of heterogeneity. The aim of this study was to compare the known driver mutations distribution among non-small cell lung cancer(NSCLC) patients with multiple intrapulmonary ground-glass nodules(GGNs). Methods: 35 consecutively resected lung cancer patients with multiple lung GGNs at a single institution (Tongji University, Shanghai, China) were analyzed for mutations in EGFR, KRAS, HER2, BRAF and PIK3CA together with genes fusion in ALK, ROS1 and RET. Results: The median age was 60 years old, male/female:12/23, never smoker/smoker: 25/10, PS 0/1: 22/13. Totally, 72 lesions were included into this analysis, including 9 of adenocarcinoma in situ, 9 minimal invasive adenocarcinoma and 54 invasive adenocarcinoma. Among them, 33 (45.8 %) tumors harbored EGFR mutations, including 13 were deletions in exon 19, 18 were L858R missense changes, and two were 19 deletion together with L858R mutations. 5 (6.9 %) harbored EML4-ALK fusions, 4 (5.6%)had HER2 mutations, 3(4.2%)had KRAS mutations, 1 had ROS1 fusion and BRAF mutation respectively. A majority of the mutations were mutually exclusive, except 1 both with EGFR mutation and ALK fusion. The discordant frequency rate of the driver mutation distribution was 68.6%(24/35) in the whole population, while it was 80%(24/30) in the patients harbored at least one of the detected driver mutations. In one of the 2 cases who had 3 resected lung lesions, exon21 L858R point mutation, exon 19 deletion, and L858R point mutation together with ALK fusion were found in the 3 tumor samples separately. Conclusions: The high incidence of inconsistent driver mutations distribution between multiple intrapulmonary nodules in this study suggested that these GGNs might arise as independent events and contributed to the higher rate of heterogeneity in intrapulmonary nodules. Patients with multiple GGNs should be given a separate staging and treatment strategy.
Effect of raloxifene on invasive breast cancer incidence in postmenopausal women stratified by Gail risk assessment: Results of the Continuing Outcomes Relevant to Evista (CORE) trial
Authors: J. A. Cauley, S. Martino, E. Barrett-Connor, T. J. Powles, J. L. Mershon, D. Disch, R. J. Secrest, S. R. Cummings
Journal: Journal of Clinical Oncology (2004)

1018 Background: Raloxifene (RLX) is approved for prevention and treatment of postmenopausal osteoporosis. Breast cancer incidence was a secondary outcome of the Multiple Outcomes of Raloxifene (MORE) trial; compared to placebo (Plc), invasive breast cancer (IBC) incidence was reduced 72% in postmenopausal women with osteoporosis receiving RLX for 4 yrs. Methods: The CORE trial, a double-blind 4-yr follow-up to MORE, examined the long-term effect of RLX on IBC incidence. All MORE participants were eligible for CORE. Information needed to assess breast cancer risk using the Gail model was not collected until the start of CORE. This pre-specified secondary CORE analysis examined the effect of RLX on incidence of IBC in women classified at low (<1.67%) vs. high (≥ 1.67%) risk of developing breast cancer over 5 yrs using the Gail model. CORE participants randomized to Plc in MORE received Plc in CORE. Those randomized to RLX 60 or 120 mg/d in MORE received RLX 60 mg/d in CORE. Time to first IBC for the two therapy groups was compared by a Cox proportional hazards model. Results: Of the 5213 MORE participants included in the CORE primary analysis, 3996 had a Gail risk assessment; 2718 received RLX 60 mg/d and 1278 received Plc during CORE. The mean 5-yr breast cancer risk for all women in CORE was 1.94; 54% met the Gail criteria for breast cancer high risk. In the Plc group, the rate of IBC was 2.7 times higher in the high-risk group than the low risk group (p=0.034). In the total cohort, there were 45 adjudicated cases of IBC (21 [0.8%] RLX vs. 24 [1.9%] Plc; hazard ratio [HR] 0.42, 95% CI 0.23, 0.75; p=0.002 vs. Plc). There were 31 IBCs (13 [0.9%] RLX vs. 18 [2.7%] Plc; HR 0.33, 95% CI 0.16, 0.67) in the high-risk group. There was no significant difference in the effect of RLX between those at low and those at high risk of breast cancer based on the Gail model (interaction p = 0.28). Conclusions: The CORE trial results provide evidence that, during years 4–8 of RLX therapy, the reduction in incidence of breast cancer in the high Gail risk group was similar to the overall reduction in incidence of breast cancer. Author Disclosure Employment or Leadership Consultant or Advisory Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration Eli Lilly & Co. Eli Lilly & Co.; Neothermia, Inc. Eli Lilly & Co.; Neothermia, Inc. Eli Lilly & Co. Eli Lilly & Co; Pfizer; Organon; NIH; DaCosta Fund for Prevention of Breast Cancer; Merck Eli Lilly & Co. Eli Lilly & Co.
Expression of COX-2 Is An Independent Unfavourable Prognostic Factor in Hodgkin Lymphoma Treated with ABVD with or without Radiotherapy.
Authors: Francisco Mestre, Antonio Gutierrez, Rafael Ramos, Jordi Martinez-Serra, Antonia Bautista, José Fuster, Pilar Lopez-Marti, Marta Casasus, Cristina Nicolau, Julio Rifa, Juan Besalduch, Juan Fernando Garcia, Jose Rodriguez
Journal: Blood (2009)
INTERDISCIPLINARY PERIPARTUM CARE OF THE PATIENT WITH DIASTOLIC HEART FAILURE IN NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Authors: Katherine Beutner, Euan Ashley, Matthew Wheeler, Victoria Parikh, Lindsay Wheeler, Valerie Hoover, Julia Platt, Heidi Salisbury, Carmen Johnson-Furlan, Robles Nancy
Journal: Journal of the American College of Cardiology (2017)
Biomarkers Predict Graft-Vs-Host Disease Outcomes Better Than Clinical Response after One Week of Treatment
Authors: Hannah Major-Monfried, Umut Ozbek, Anne S. Renteria, Matthew J Hartwell, Attaphol Pawarode, Gregory A. Yanik, Francis A Ayuk, Ernst Holler, Yvonne A Efebera, William J Hogan, Muna Qayed, Elizabeth O. Hexner, Kitsada Wudhikarn, Matthias Wolfl, Rainer Ordemann, Stephan Mielke, Udomsak Bunworasate, Steven M. Devine, Nicolaus Kroeger, Monzr Al-Malki, Yi-Bin Chen, Andrew C. Harris, Madan H. Jagasia, Carrie L Kitko, Mark R Litzow, Franco Locatelli, Ryotaro Nakamura, Pavan R. Reddy, Ran Reshef, Wolf Roesler, Daniela Weber, James Ferrara, John E. Levine
Journal: Blood (2016)
Comparison of clinical outcome between gefitinib and erlotinib treatment in patients with non-small cell lung cancer harboring an epidermal growth factor receptor exon 19 or exon 21 mutations.
Authors: Sung Hee Lim, Ji Yoon Lee, Jong-Mu Sun, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Journal: Journal of Clinical Oncology (2013)

e19051 Background: Gefitinib and erlotinib are small-molecule kinase inhibitors that inhibit signaling via EGFR and both agents showed dramatic response rate and prolonged PFS in patients harboring activating EGFR mutation. We investigated the clinical outcomes between gefitinib- and erlotinib-treated patients with recurrent or metastatic non-small cell lung cancer (NSCLC) harboring EGFR mutations. Methods: A total 375 patients with recurrent or metastatic NSCLC who had either an exon 19 deletion or L858R mutation on exon 21 and received gefitinib (n=228) or erlotinib (n=147) therapy between August 2007 and December 2011 were retrospectively reviewed. By using a matched-pair case-control study design, 121 pairs of gefitinib-treated and erlotinib-treated patients were matched according to sex, smoking history, ECOG performance status, and types of EGFR mutation. Results: The median age of all patients was 58 years (range, 30-84) and more than half of patients were never smokers (63.6%). Most patients had adenocarcinoma (98.3%) and good ECOG performance status (0, 1) (90.9%). Of 242 patients, 64 (26.4%) received an EGFR TKI as first line therapy. The overall response rates and disease control rates in the gefitinib-treated and erlotinib-treated groups were 85.5% versus 79.8 % (p=.375) and 94.0% versus 89.1%, respectively (p=.242). There was no statistically significant difference noted with regard to OS (median, 38.9 vs 37.5; p=.642) and PFS (median, 12.9 vs 10.1; p=.135) between the gefitinib-treated and erlotinib-treated groups. For a subgroup which patients were treated with TKI as first line therapy, the overall response rates were higher than those of patients who had progressed on prior chemotherapy (90.3% vs 79.9%; p=.063). However, there was no significant difference in PFS (median, 13.3 vs 10.3; p=.134) between subjects with first line TKI therapy and more than second line treatment. Conclusions: Both gefitinib and erlotinib showed similar effective activity in selected population of NSCLC that harbored an EGFR mutation and further studies are needed to evaluate the efficacy of EGFR TKI as first line treatment.
AORTIC STENOSIS, BUT NOT MITRAL OR AORTIC REGURGITATION, IS ASSOCIATED WITH ADVERSE OUTCOMES WITH ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL
Authors: Alice Wang, John Alexander, Hillary Mulder, Renato Lopes, Petr Jansky, Basil Lewis, Bernard Gersh, Alvaro Avezum, Michael Hanna, Claes Held, Lars Wallentin, Christopher Granger, Dragos Vinereanu
Journal: Journal of the American College of Cardiology (2017)
GENDER-BASED OUTCOMES IN DIABETICS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
Authors: Vincent Gacad, Ricardo Bellera, Ignacio De Cicco, Yelin Zhao, Fiorella Llanos-Chea, Cameron McBride, Biswajit Kar, Prakash Balan, Richard Smalling, Igor Gregoric, Pranav Loyalka, Tom Nguyen, Abhijeet Dhoble
Journal: Journal of the American College of Cardiology (2017)
CORRELATION BETWEEN FRAILTY AND NON-INVASIVE CORONARY FLOW RESERVE: A CROSS SECTIONAL STUDY
Authors: Amjad M. Ahmed, Ihab Sulaiman, Mousa Alfaris, Dalia Ahmed, Ahmed Aljizeeri, Abdelrahman Jamiel, Abdulbaset Sulaiman, Mouaz Al-Mallah
Journal: Journal of the American College of Cardiology (2017)
APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR INTERVENTIONS IN PROBANDS AND FAMILY MEMBERS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY DYSPLASIA
Authors: Gabriela Orgeron, Cynthia James, Crystal Tichnell, Brittney Murray, Bryana Rivers, Harikrishna Tandri, Hugh Calkins
Journal: Journal of the American College of Cardiology (2017)
Irradiated NK-92 Targets AML Leukemic Stem Cells in Vivo and Gene-Modified CD16+NK-92 Mediates Antibody Dependent Cell Mediated Cytotoxicity (ADCC) Against CD123+ Cells
Authors: Brent A. Williams, Xing-Hua Wang, Sonam Maghera, Jeffrey V. Leyton, Raymond Reilly, Armand Keating
Journal: Blood (2012)